Literature DB >> 21779514

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.

Noa Rivlin1, Ran Brosh, Moshe Oren, Varda Rotter.   

Abstract

Inactivation of the p53 tumor suppressor is a frequent event in tumorigenesis. In most cases, the p53 gene is mutated, giving rise to a stable mutant protein whose accumulation is regarded as a hallmark of cancer cells. Mutant p53 proteins not only lose their tumor suppressive activities but often gain additional oncogenic functions that endow cells with growth and survival advantages. Interestingly, mutations in the p53 gene were shown to occur at different phases of the multistep process of malignant transformation, thus contributing differentially to tumor initiation, promotion, aggressiveness, and metastasis. Here, the authors review the different studies on the involvement of p53 inactivation at various stages of tumorigenesis and highlight the specific contribution of p53 mutations at each phase of cancer progression.

Entities:  

Keywords:  cancer; mutant; p53; tumorigenesis

Year:  2011        PMID: 21779514      PMCID: PMC3135636          DOI: 10.1177/1947601911408889

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  120 in total

1.  Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma.

Authors:  Hong-Yi Cai; Xiao-Hu Wang; Ying Tian; Li-Ying Gao; Li-Juan Zhang; Zhi-Yan Zhang
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Geographic variation of p53 mutational profile in nonmalignant human liver.

Authors:  F Aguilar; C C Harris; T Sun; M Hollstein; P Cerutti
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

Review 3.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 6.  TP53 and liver carcinogenesis.

Authors:  Frank Staib; S Perwez Hussain; Lorne J Hofseth; Xin W Wang; Curtis C Harris
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

Authors:  J M Birch; V Blair; A M Kelsey; D G Evans; M Harris; K J Tricker; J M Varley
Journal:  Oncogene       Date:  1998-09-03       Impact factor: 9.867

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  281 in total

1.  Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.

Authors:  Ellen Heitzer; Sandra Sunitsch; Magdalena M Gilg; Birgit Lohberger; Beate Rinner; Karl Kashofer; Nicole Stündl; Peter Ulz; Joanna Szkandera; Andreas Leithner; Bernadette Liegl-Atzwanger
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

Review 2.  High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer.

Authors:  Agnieszka B Bialkowska; Vincent W Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

Review 3.  The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure.

Authors:  Gwen A Lomberk; Raul Urrutia
Journal:  Surg Clin North Am       Date:  2015-07-23       Impact factor: 2.741

Review 4.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

5.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

6.  Regulation of glycolysis in head and neck squamous cell carcinoma.

Authors:  Dhruv Kumar
Journal:  Postdoc J       Date:  2017-01

7.  Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression.

Authors:  Min-Kyeong Kim; Ji-Yang Song; Dong-In Koh; Jin Young Kim; Masahiko Hatano; Bu-Nam Jeon; Min-Young Kim; Su-Yeon Cho; Kyung-Sup Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

8.  Murine embryonic fibroblast cell lines differentiate into three mesenchymal lineages to different extents: new models to investigate differentiation processes.

Authors:  Khaled Dastagir; Kerstin Reimers; Andrea Lazaridis; Sabrina Jahn; Viktor Maurer; Sarah Strauß; Nadjib Dastagir; Christine Radtke; Andreas Kampmann; Vesna Bucan; Peter M Vogt
Journal:  Cell Reprogram       Date:  2014-08       Impact factor: 1.987

Review 9.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

10.  Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.

Authors:  Krzysztof Flisikowski; Marek Switonski; Agata Sikorska; Tatiana Flisikowska; Monika Stachowiak; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2018-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.